10-Q: Hestia Insight Inc. Reports Q3 2026 Results Amidst Going Concern Doubts

Hestia Insight Inc. filed its Q3 2026 10-Q, revealing no revenue, significant operating losses, and substantial doubt about its ability to continue as a going concern following the disposal of its operating subsidiary.

Summary

• Hestia Insight Inc. reported its quarterly results for the period ending August 31, 2026.
• The company generated no revenue during the nine months ended August 31, 2026, similar to the prior year's period.
• Operating expenses for the nine months ended August 31, 2026, were $534,461, an increase from $198,554 in the prior year, largely due to a $500,000 officer compensation accrual.
• The company reported a net loss of $441,239 for the nine months ended August 31, 2026, compared to a net loss of $934,426 for the same period in 2025.
• As of August 31, 2026, the company had cash of $3,852 and total liabilities of $343,703, including $223,931 in related party loans.
• The company disposed of its subsidiary, Hestia Investments Inc., on July 31, 2026, which carried out all of the company's consulting and investment activities.
• Substantial doubt exists regarding the company's ability to continue as a going concern within one year due to its lack of revenue-generating operations and significant liabilities.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to the company's continued lack of revenue, significant operating losses, and substantial doubt about its ability to continue as a going concern, despite the disposal of its operating subsidiary.

Positives

• The disposal of the operating subsidiary, Hestia Investments Inc., on July 31, 2026, settled a $500,000 accrued compensation liability to the Chairman and CEO.
• The company has a proprietary artificial intelligence platform for capital markets advisory and business consulting.
• The company is exploring strategic acquisitions and licensing opportunities in the healthcare and biotech sectors.

Negatives

• The company generated zero revenue for the nine months ended August 31, 2026.
• Operating expenses increased significantly to $534,461 for the nine months ended August 31, 2026, primarily due to a $500,000 officer compensation accrual.
• The company reported a net loss of $441,239 for the nine months ended August 31, 2026.
• Cash and cash equivalents were only $3,852 as of August 31, 2026.
• Total liabilities stood at $343,703 as of August 31, 2026, with a significant portion ($223,931) being related party loans.
• The company has substantial doubt about its ability to continue as a going concern within one year.
• The company has no operating subsidiaries and is considering 'other sustainable arrangements'.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern within one year after the financial statements are issued.
• The company has no revenue-generating operations following the disposal of its subsidiary.
• The company's future operations are dependent on its ability to secure additional financing, which is not assured.
• The company has no agreements or arrangements to obtain funds through bank loans or lines of credit.
• The company has no patents and has not applied for patent protection, posing a risk to intellectual property rights.
• The company's business is subject to the highly regulated healthcare industry, with uncertain future regulations.
• The company's disclosure controls and procedures were found to be ineffective as of May 31, 2026.

Future Outlook

The company's future operations are highly uncertain and dependent on its ability to secure additional financing, potentially through equity financing, advances from its Chairman, or a merger or acquisition. Without additional capital, the company may be forced to cease operations.

Management Comments

• Management plans to fund operations through advances from its Chairman, equity financing and a potential merger or acquisition.
• There is no assurance these plans will succeed, and if they do not, investors could lose their entire investment in the Company.
• The Company currently has no operating subsidiaries and is considering other sustainable arrangements for the near future.

Industry Context

StockSavvy.ai notes that Hestia Insight Inc. operates in the capital markets advisory and business consulting sector, focusing on emerging growth companies. The company's current financial distress and lack of revenue place it in a challenging position within this competitive landscape, especially given its reliance on AI technology which is a rapidly evolving field.

Comparison to Industry Standards

• The company's lack of revenue and significant operating losses are not in line with industry standards for successful consulting or advisory firms, which typically generate substantial fees based on client engagements.
• Competitors in the AI-powered capital markets advisory space often have established track records, significant funding, and demonstrable revenue streams, which Hestia Insight Inc. currently lacks.
• The company's reliance on related party loans and the ongoing concern about its ability to continue as a going concern are critical deviations from industry norms for financially stable companies.

Corporate Governance

Legal Proceedings

• The company is not presently a party to any legal proceedings that, if determined adversely, would individually or taken together have a material adverse effect on its business, operating results, financial condition, or cash flows.

Related Party Transactions

• As of August 31, 2026, related party loans payable totaled $223,931, including $75,000 from ECL Capital Partners Corp and $148,931 from Mr. Edward Lee.
• A $50,000 note payable to ECL Capital Partners Corp, owned by CEO Mr. Edward Lee, originally due January 15, 2025, was extended to January 15, 2026, and remains outstanding.
• A $25,000 note payable to ECL Capital Partners Corp was due August 24, 2025.
• Multiple notes payable to Mr. Edward Lee totaling $148,931 were outstanding as of August 31, 2026, with various repayment dates in 2026 and 2027.
• A short-term loan of $16,670 from Mr. Edward Lee was outstanding as of August 31, 2026.
• On July 31, 2026, the company transferred its subsidiary Hestia Investments Inc. to Mr. Edward Lee in exchange for the settlement of $500,000 in accrued compensation.

Stakeholder Impact

• Shareholders face significant risk of losing their entire investment due to the company's going concern issues and lack of revenue.
• Creditors and lenders (including related parties) face uncertainty regarding the repayment of outstanding loans.
• Employees may face job insecurity given the company's precarious financial situation and lack of operating subsidiaries.

Next Steps

• Management plans to seek equity financing, advances from its Chairman, or a potential merger or acquisition to fund operations.
• The company is considering other sustainable arrangements for its future operations.
• The company will continue to evaluate its accounting policies and estimates.

Key Dates

Recommendation

The company exhibits severe financial distress, including zero revenue, significant operating losses, critically low cash reserves, and substantial doubt about its ability to continue as a going concern. The disposal of its only operating subsidiary further exacerbates its precarious position. Without a clear path to revenue generation or a viable financing strategy, the risk to investors is exceptionally high.

Keywords

AI-powered capital markets advisory, business consulting, fundraising solutions, emerging growth companies, discontinued operations, going concern, related party loans, officer compensation